Genetic polymorphisms associated with rubella virus-specific cellular immunity following MMR vaccination

Human Genetics

Volumn 133, Issue 11, 2014, Pages 1407-1417

  Kennedy, Richard B ^a   Ovsyannikova, Inna G ^a   Haralambieva, Iana H ^a   Lambert, Nathaniel D ^a   Pankratz, V Shane ^a   Poland, Gregory A ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE DEAMINASE; ALPHA INTERFERON RECEPTOR; ASTROTACTIN 2; BUTYROPHILIN 3 ALPHA 1; BUTYROPHILIN 3 ALPHA 3; CELL ADHESION MOLECULE; CYTOKINE RECEPTOR; DNA TOPOISOMERASE; GAMMA INTERFERON; INTERFERON ALPHA RECEPTOR 1; INTERLEUKIN 10 RECEPTOR BETA; INTERLEUKIN 2; INTERLEUKIN 6; INTERLEUKIN 6 RECEPTOR; MEASLES MUMPS RUBELLA VACCINE; POLIOVIRUS RECEPTOR L1; POLIOVIRUS RECEPTOR L2; PROTEIN; TOLL LIKE RECEPTOR 4; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; VIRUS RECEPTOR; CYTOKINE;

ADULT; ARTICLE; CAUCASIAN; CELLULAR IMMUNITY; CYTOKINE RELEASE; FEMALE; GENETIC ASSOCIATION; GENOTYPE; HUMAN; IMMUNE RESPONSE; MALE; NONHUMAN; NORMAL HUMAN; RUBELLA VIRUS; RUBELLA VIRUS SPECIFIC CELLULAR IMMUNITY; SINGLE NUCLEOTIDE POLYMORPHISM; VACCINATION; ADOLESCENT; CHILD; COHORT ANALYSIS; GENETICS; IMMUNOLOGY; META ANALYSIS; PHENOTYPE; RUBELLA; SPECIES DIFFERENCE; YOUNG ADULT;

RUBELLA VIRUS;

ADOLESCENT; ADULT; CHILD; COHORT STUDIES; CYTOKINES; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GENOTYPE; HUMANS; IMMUNITY, CELLULAR; MALE; MEASLES-MUMPS-RUBELLA VACCINE; PHENOTYPE; POLYMORPHISM, SINGLE NUCLEOTIDE; RECEPTORS, CYTOKINE; RUBELLA; RUBELLA VIRUS; SPECIES SPECIFICITY; VACCINATION; YOUNG ADULT;

EID: 84919462097     PISSN: 03406717     EISSN: 14321203     Source Type: Journal    
DOI: 10.1007/s00439-014-1471-z     Document Type: Article

References (49)

1. (2013) Nationwide rubella epidemic–Japan, 2013. MMWR. Morbidity and mortality weekly report 62: 457–62
2. Bottino C, Castriconi R, Pende D, Rivera P, Nanni M, Carnemolla B, Cantoni C, Grassi J, Marcenaro S, Reymond N, Vitale M, Moretta L, Lopez M, Moretta A (2003) Identification of PVR (CD155) and Nectin-2 (CD112) as cell surface ligands for the human DNAM-1 (CD226) activating molecule. J Exp Med 198:557–567. doi:10.1084/jem.20030788
3. Carlson CS, Eberle MA, Rieder MJ, Yi Q, Kruglyak L, Nickerson DA (2004) Selecting a maximally informative set of single-nucleotide polymorphisms for association analyses using linkage disequilibrium. Am J Hum Genet 74:106–120. doi:10.1086/381000
4. Dhiman N, Ovsyannikova IG, Cunningham JM, Vierkant RA, Kennedy RB, Pankratz VS, Poland GA, Jacobson RM (2007) Associations between measles vaccine immunity and single-nucleotide polymorphisms in cytokine and cytokine receptor genes. J Infect Dis 195:21–29. doi:10.1086/510596
5. Dhiman N, Ovsyannikova IG, Vierkant RA, Pankratz VS, Jacobson RM, Poland GA (2008) Associations between cytokine/cytokine receptor single nucleotide polymorphisms and humoral immunity to measles, mumps and rubella in a Somali population. Tissue Antigens 72:211–220. doi:10.1111/j.1399-0039.2008.01097.x
6. Dhiman N, Haralambieva IH, Kennedy RB, Vierkant RA, O’Byrne MM, Ovsyannikova IG, Jacobson RM, Poland GA (2010a) SNP/haplotype associations in cytokine and cytokine receptor genes and immunity to rubella vaccine. Immunogenetics 62:197–210. doi:10.1007/s00251-010-0423-6
7. Dhiman N, Haralambieva IH, Vierkant RA, Pankratz VS, Ryan JE, Jacobson RM, Ovsyannikova IG, Poland GA (2010b) Predominant inflammatory cytokine secretion pattern in response to two doses of live rubella vaccine in healthy vaccinees. Cytokine 50:24–29. doi:10.1016/j.cyto.2009.12.002
8. Fuchs A, Cella M, Giurisato E, Shaw AS, Colonna M (2004) Cutting edge: CD96 (tactile) promotes NK cell-target cell adhesion by interacting with the poliovirus receptor (CD155). J Immunol 172:3994–3998
9. Greenland S, O'Rourke K (2008) Meta-analysis. In: Rothman KJ, Greenland S, Lash TL (eds) Modern Epidemiology, 3rd edn. Lippincott Williams and Wilkins, Philadelphia, PA, pp 652–682
10. Haralambieva IH, Dhiman N, Ovsyannikova IG, Vierkant RA, Pankratz VS, Jacobson RM, Poland GA (2010) 2′-5′-Oligoadenylate synthetase single-nucleotide polymorphisms and haplotypes are associated with variations in immune responses to rubella vaccine. Hum Immunol 71:383–391. doi:10.1016/j.humimm.2010.01.004
11. Haralambieva IH, Ovsyannikova IG, Umlauf BJ, Vierkant RA, Shane Pankratz V, Jacobson RM, Poland GA (2011) Genetic polymorphisms in host antiviral genes: associations with humoral and cellular immunity to measles vaccine. Vaccine 29:8988–8997. doi:10.1016/j.vaccine.2011.09.043
12. Honeyman MC, Forrest JM, Dorman DC (1974) Cell-mediated immune response following natural rubella and rubella vaccination. Clin Exp Immunol 17:665–671
13. Hwang Y, Chen EY, Gu ZJ, Chuang WL, Yu ML, Lai MY, Chao YC, Lee CM, Wang JH, Dai CY, Shian-Jy Bey M, Liao YT, Chen PJ, Chen DS (2006) Genetic predisposition of responsiveness to therapy for chronic hepatitis C. Pharmacogenomics 7:697–709. doi:10.2217/14622416.7.5.697
14. Jacobsen SJ, Ackerson BK, Sy LS, Tran TN, Jones TL, Yao JF, Xie F, Cheetham TC, Saddier P (2009) Observational safety study of febrile convulsion following first dose MMRV vaccination in a managed care setting. Vaccine 27:4656–4661. doi:10.1016/j.vaccine.2009.05.056
15. Jacobson RM, Ovsyannikova IG, Poland GA (2009) Genetic basis for variation of vaccine response: our studies with rubella vaccine. Paediatr Child Health 19:S156–S159. doi:10.1016/j.paed.2009.08.019
16. Kennedy RB, Ovsyannikova IG, Pankratz VS, Vierkant RA, Jacobson RM, Ryan MA, Poland GA (2009) Gender effects on humoral immune responses to smallpox vaccine. Vaccine 27:3319–3323. doi:10.1016/j.vaccine.2009.01.086
17. Kennedy RB, Ovsyannikova IG, Vierkant RA, Jacobson RM, Poland GA (2010) Effect of human leukocyte antigen homozygosity on rubella vaccine-induced humoral and cell-mediated immune responses. Hum Immunol 71:128–135. doi:10.1016/j.humimm.2009.11.002
18. Khor CC, Vannberg FO, Chapman SJ, Walley A, Aucan C, Loke H, White NJ, Peto T, Khor LK, Kwiatkowski D, Day N, Scott A, Berkley JA, Marsh K, Peshu N, Maitland K, Williams TN, Hill AV (2007) Positive replication and linkage disequilibrium mapping of the chromosome 21q22.1 malaria susceptibility locus. Genes Immun 8:570–576. doi:10.1038/sj.gene.6364417
19. Klein NP, Fireman B, Yih WK, Lewis E, Kulldorff M, Ray P, Baxter R, Hambidge S, Nordin J, Naleway A, Belongia EA, Lieu T, Baggs J, Weintraub E (2010) Measles-mumps-rubella-varicella combination vaccine and the risk of febrile seizures. Pediatrics 126:e1–e8. doi:10.1542/peds.2010-0665
20. Marin M, Broder KR, Temte JL, Snider DE, Seward JF (2010) Use of combination measles, mumps, rubella, and varicella vaccine: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR. Recommendations and reports: Morbidity and mortality weekly report. Recommendations and reports/Centers for Disease Control 59: 1–12
21. Metcalf CJ, Lessler J, Klepac P, Cutts F, Grenfell BT (2012) Impact of birth rate, seasonality and transmission rate on minimum levels of coverage needed for rubella vaccination. Epidemiol Infect 140:2290–2301. doi:10.1017/S0950268812000131
22. Mitchell LA, Tingle AJ, Decarie D, Shukin R (1999) Identification of rubella virus T-cell epitopes recognized in anamnestic response to RA27/3 vaccine: associations with boost in neutralizing antibody titer. Vaccine 17:2356–2365
23. Ovsyannikova IG, Jacobson RM, Vierkant RA, Jacobsen SJ, Pankratz VS, Poland GA (2004) The contribution of HLA class I antigens in immune status following two doses of rubella vaccination. Hum Immunol 65:1506–1515. doi:10.1016/j.humimm.2004.07.001
24. Ovsyannikova IG, Jacobson RM, Vierkant RA, Jacobsen SJ, Pankratz VS, Poland GA (2005) Human leukocyte antigen class II alleles and rubella-specific humoral and cell-mediated immunity following measles-mumps-rubella-II vaccination. J Infect Dis 191:515–519. doi:10.1086/427558
25. Ovsyannikova IG, Pankratz VS, Vierkant RA, Jacobson RM, Poland GA (2006) Human leukocyte antigen haplotypes in the genetic control of immune response to measles-mumps-rubella vaccine. J Infect Dis 193:655–663. doi:10.1086/500144
26. Ovsyannikova IG, Jacobson RM, Vierkant RA, O’Byrne MM, Poland GA (2009a) Replication of rubella vaccine population genetic studies: validation of HLA genotype and humoral response associations. Vaccine 27:6926–6931. doi:10.1016/j.vaccine.2009.08.109
27. Ovsyannikova IG, Ryan JE, Vierkant RA, O’Byrne MM, Pankratz VS, Jacobson RM, Poland GA (2009b) Influence of host genetic variation on rubella-specific T cell cytokine responses following rubella vaccination. Vaccine 27:3359–3366. doi:10.1016/j.vaccine.2009.01.079
28. Ovsyannikova IG, Dhiman N, Haralambieva IH, Vierkant RA, O’Byrne MM, Jacobson RM, Poland GA (2010a) Rubella vaccine-induced cellular immunity: evidence of associations with polymorphisms in the Toll-like, vitamin A and D receptors, and innate immune response genes. Hum Genet 127:207–221. doi:10.1007/s00439-009-0763-1
29. Ovsyannikova IG, Haralambieva IH, Dhiman N, O’Byrne MM, Pankratz VS, Jacobson RM, Poland GA (2010b) Polymorphisms in the vitamin A receptor and innate immunity genes influence the antibody response to rubella vaccination. J Infect Dis 201:207–213. doi:10.1086/649588
30. Ovsyannikova IG, Vierkant RA, Pankratz VS, Jacobson RM, Poland GA (2010c) Extended LTA, TNF, LST1 and HLA gene haplotypes and their association with rubella vaccine-induced immunity. PLoS One 5:e11806. doi:10.1371/journal.pone.0011806
31. Ovsyannikova IG, Haralambieva IH, Vierkant RA, O’Byrne MM, Jacobson RM, Poland GA (2011a) The association of CD46, SLAM and CD209 cellular receptor gene SNPs with variations in measles vaccine-induced immune responses: a replication study and examination of novel polymorphisms. Hum Hered 72:206–223. doi:10.1159/000331585
32. Ovsyannikova IG, Vierkant RA, Pankratz VS, Jacobson RM, Poland GA (2011b) Human leukocyte antigen genotypes in the genetic control of adaptive immune responses to smallpox vaccine. J Infect Dis 203:1546–1555. doi:10.1093/infdis/jir167
33. Ovsyannikova IG, Haralambieva IH, Kennedy RB, Pankratz VS, Vierkant RA, Jacobson RM, Poland GA (2012a) Impact of cytokine and cytokine receptor gene polymorphisms on cellular immunity after smallpox vaccination. Gene 510:59–65. doi:10.1016/j.gene.2012.08.021
34. Ovsyannikova IG, Pankratz VS, Vierkant RA, Jacobson RM, Poland GA (2012b) Consistency of HLA associations between two independent measles vaccine cohorts: a replication study. Vaccine 30:2146–2152. doi:10.1016/j.vaccine.2012.01.038
35. Pankratz VS, Vierkant RA, O’Byrne MM, Ovsyannikova IG, Poland GA (2010) Associations between SNPs in candidate immune-relevant genes and rubella antibody levels: a multigenic assessment. BMC Immunol 11:48. doi:10.1186/1471-2172-11-48
36. Reef SE, Plotkin SA (2013) Rubella vaccine. In: Plotkin SA, Orenstein WA, Offit PA (eds) Vaccines, 6th edn. Elsevier/Saunders, Edinburgh, pp xix, 1550 p
37. Romporn S, Hirankarn N, Tangkijvanich P, Kimkong I (2013) Association of IFNAR2 and IL10RB genes in chronic hepatitis B virus infection. Tissue Antigens 82:21–25. doi:10.1111/tan.12133
38. Sakisaka T, Takai Y (2004) Biology and pathology of nectins and nectin-like molecules. Curr Opin Cell Biol 16:513–521. doi:10.1016/j.ceb.2004.07.007
39. Sawcer S, Hellenthal G, Pirinen M, Spencer CC, Patsopoulos NA, Moutsianas L, Dilthey A, Su Z, Freeman C, Hunt SE, Edkins S, Gray E, Booth DR, Potter SC, Goris A, Band G, Oturai AB, Strange A, Saarela J, Bellenguez C, Fontaine B, Gillman M, Hemmer B, Gwilliam R, Zipp F, Jayakumar A, Martin R, Leslie S, Hawkins S, Giannoulatou E, D’Alfonso S, Blackburn H, Martinelli Boneschi F, Liddle J, Harbo HF, Perez ML, Spurkland A, Waller MJ, Mycko MP, Ricketts M, Comabella M, Hammond N, Kockum I, McCann OT, Ban M, Whittaker P, Kemppinen A, Weston P, Hawkins C, Widaa S, Zajicek J, Dronov S, Robertson N, Bumpstead SJ, Barcellos LF, Ravindrarajah R, Abraham R, Alfredsson L, Ardlie K, Aubin C, Baker A, Baker K, Baranzini SE, Bergamaschi L, Bergamaschi R, Bernstein A, Berthele A, Boggild M, Bradfield JP, Brassat D, Broadley SA, Buck D, Butzkueven H, Capra R, Carroll WM, Cavalla P, Celius EG, Cepok S, Chiavacci R, Clerget-Darpoux F, Clysters K, Comi G, Cossburn M, Cournu-Rebeix I, Cox MB, Cozen W, Cree BA, Cross AH, Cusi D, Daly MJ, Davis E, de Bakker PI, Debouverie M, D’Hooghe MB, Dixon K, Dobosi R, Dubois B, Ellinghaus D, Elovaara I, Esposito F et al (2011) Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis. Nature 476:214–219. doi:10.1038/nature10251
40. Shrestha S, Wiener HW, Aissani B, Song W, Shendre A, Wilson CM, Kaslow RA, Tang J (2010) Interleukin-10 (IL-10) pathway: genetic variants and outcomes of HIV-1 infection in African American adolescents. PLoS One 5:e13384. doi:10.1371/journal.pone.0013384
41. Sicotte H, Rider DN, Poland GA, Dhiman N, Kocher JP (2011) SNPPicker: high quality tag SNP selection across multiple populations. BMC Bioinform 12:129. doi:10.1186/1471-2105-12-129
42. Storey JD (2002) A direct approach to false discovery rates. J Royal Stat Soc Ser B Stat Methodol 64:479–498. doi:10.1111/1467-9868.00346
43. Storey JD (2003) The positive false discovery rate: a Bayesian interpretation and the q-value. Ann Stat 31:2013–2035. doi:10.2307/3448445
44. Till A, Rosenstiel P, Krippner-Heidenreich A, Mascheretti-Croucher S, Croucher PJ, Schafer H, Scheurich P, Seegert D, Schreiber S (2005) The Met-196 - > Arg variation of human tumor necrosis factor receptor 2 (TNFR2) affects TNF-alpha-induced apoptosis by impaired NF-kappaB signaling and target gene expression. J Biol Chem 280:5994–6004. doi:10.1074/jbc.M411541200
45. Vesikari T, Buimovici-Klein E (1975) Lymphocyte responses to rubella antigen and phytohemagglutinin after administration of the RA 27/3 strain of live attenuated rubella vaccine. Infect Immun 11:748–753
46. Vesikari T, Becker T, Gajdos V, Fiquet A, Thomas S, Richard P, Baudin M (2012) Immunogenicity and safety of a two-dose regimen of a combined measles, mumps, rubella and varicella live vaccine (ProQuad((R))) in infants from 9 months of age. Vaccine 30:3082–3089. doi:10.1016/j.vaccine.2012.02.062
47. Welzel TM, Morgan TR, Bonkovsky HL, Naishadham D, Pfeiffer RM, Wright EC, Hutchinson AA, Crenshaw AT, Bashirova A, Carrington M, Dotrang M, Sterling RK, Lindsay KL, Fontana RJ, Lee WM, Di Bisceglie AM, Ghany MG, Gretch DR, Chanock SJ, Chung RT, O’Brien TR (2009) Variants in interferon-alpha pathway genes and response to pegylated interferon-Alpha2a plus ribavirin for treatment of chronic hepatitis C virus infection in the hepatitis C antiviral long-term treatment against cirrhosis trial. Hepatology 49:1847–1858. doi:10.1002/hep.22877
48. Xu Z, Jin B (2010) A novel interface consisting of homologous immunoglobulin superfamily members with multiple functions. Cell Mol Immunol 7:11–19. doi:10.1038/cmi.2009.108
49. Yu X, Harden K, Gonzalez LC, Francesco M, Chiang E, Irving B, Tom I, Ivelja S, Refino CJ, Clark H, Eaton D, Grogan JL (2009) The surface protein TIGIT suppresses T cell activation by promoting the generation of mature immunoregulatory dendritic cells. Nat Immunol 10:48–57. doi:10.1038/ni.1674